Evaluation of the Antitumor Activity by Ni Nanoparticles with Verbascoside
Figure 5
Inhibit the tumor growth in K652/ADM mice with VB-Ni treatments. (a) and (b) Tumor volumes in mice treated with various regents. Cancer cells were injected into the abdominal area of mice (plus a magnet fixed under skin close to the tumor site). When the tumors reached a minimal size of 300 mm3, mice were divided to 3 groups with 3–5 mice in each group. The mouse groups received various reagents every other day by tail-vein injections. (c) The weight of tumor in (a).
